Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P G Harper

Showing results (101-110 of 125) with videos related to

Pageof 13
Sort By:
British Journal of Cancer|January 1, 1990
The response of cerebral metastases in small cell lung cancer to systemic chemotherapyC J Twelves, R L Souhami, P G Harper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Treatment of invasive thymoma with single-agent ifosfamideM S Highley, C R Underhill, F X Parnis, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Mitomycin, ifosfamide and cisplatin in non-small-cell lung cancerD C Currie, D W Miles, J S Drake, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1995
Formation of chloroethylamine and 1,3-oxazolidine-2-one following ifosfamide administration in humansM S Highley, G Momerency, K Van Cauwenberghe, et al.
Gynecologic Oncology|April 29, 2006
Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First StudyC B Steer, K Chrystal, K A Cheong, et al.
British Journal of Cancer|October 29, 1998
A randomized trial comparing methotrexate and vinblastine (MV) with cisplatin, methotrexate and vinblastine (CMV) in advanced transitional cell carcinoma: results and a report on prognostic factors in a Medical Research Council study. MRC Advanced Bladder Cancer Working PartyG M Mead, M Russell, P Clark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1985
High-dose cyclophosphamide in small-cell carcinoma of the lungR L Souhami, G Finn, W M Gregory, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 1998
Activated oxazaphosphorines are transported predominantly by erythrocytesM S Highley, D Schrijvers, A T Van Oosterom, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1991
Intensive weekly chemotherapy for good-prognosis patients with small-cell lung cancerD W Miles, H M Earl, R L Souhami, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
A phase II study of ifosfamide in advanced and relapsed carcinoma of the cervixR E Coleman, P G Harper, C Gallagher, et al.
Pageof 13

Showing results (101-110 of 125) with videos related to

Sort By:
Pageof 13
British Journal of Cancer|January 1, 1990
The response of cerebral metastases in small cell lung cancer to systemic chemotherapyC J Twelves, R L Souhami, P G Harper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Treatment of invasive thymoma with single-agent ifosfamideM S Highley, C R Underhill, F X Parnis, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Mitomycin, ifosfamide and cisplatin in non-small-cell lung cancerD C Currie, D W Miles, J S Drake, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1995
Formation of chloroethylamine and 1,3-oxazolidine-2-one following ifosfamide administration in humansM S Highley, G Momerency, K Van Cauwenberghe, et al.
Gynecologic Oncology|April 29, 2006
Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First StudyC B Steer, K Chrystal, K A Cheong, et al.
British Journal of Cancer|October 29, 1998
A randomized trial comparing methotrexate and vinblastine (MV) with cisplatin, methotrexate and vinblastine (CMV) in advanced transitional cell carcinoma: results and a report on prognostic factors in a Medical Research Council study. MRC Advanced Bladder Cancer Working PartyG M Mead, M Russell, P Clark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1985
High-dose cyclophosphamide in small-cell carcinoma of the lungR L Souhami, G Finn, W M Gregory, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 1998
Activated oxazaphosphorines are transported predominantly by erythrocytesM S Highley, D Schrijvers, A T Van Oosterom, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1991
Intensive weekly chemotherapy for good-prognosis patients with small-cell lung cancerD W Miles, H M Earl, R L Souhami, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
A phase II study of ifosfamide in advanced and relapsed carcinoma of the cervixR E Coleman, P G Harper, C Gallagher, et al.
Pageof 13